Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India

Author:

Bansal Naveen,Raturi Manish,Bansal Yashik

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology

Reference14 articles.

1. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China;Ye;J Med Virol,2020

2. COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors [published online ahead of print, 2021 May 7];Bansal;Transfus Clin Biol,2021

3. Convalescent Plasma Therapy for COVID-19: State of the Art;Focosi;Clin Microbiol Rev,2020

4. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) [published correction appears in BMJ. 2020 Nov 3;371:m4232];Agarwal;BMJ,2020

5. Indian Council of Medical Research. Evidence Based Advisory to address Inappropriate Use of Convalescent Plasma in COVID-19 Patients. Published 17-11-2020. [Accessed 19-05-2021]. https://www.icmr.gov.in/pdf/covid/techdoc/ICMR_ADVISORY_Convalescent_plasma_17112020_v1.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3